{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:57:50Z","timestamp":1787237870135,"version":"build-2736575974"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:00:00Z","timestamp":1615939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000774","name":"Defense Threat Reduction Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Q fever is caused by the obligate intracellular bacterium,\n                    <jats:italic>Coxiella burnetii<\/jats:italic>\n                    , a designated potential agent of bioterrorism because of its route of transmission, resistance to disinfectants, and low infectious dose. The only vaccine licensed for human use is Q-VAX\n                    <jats:sup>\u00ae<\/jats:sup>\n                    (Seqirus, licensed in Australia), a formalin-inactivated whole-cell vaccine, which produces severe local and systemic reactogenic responses in previously sensitized individuals. Accordingly, the U.S. Food and Drug Administration and other regulatory bodies around the world, have been reluctant to approve Q-VAX for widespread use. To obviate these adverse reactions, we prepared recombinant protein subunit vaccine candidates containing purified CBU1910, CBU0307, CBU0545, CBU0612, CBU0891, and CBU1398 proteins and TLR triagonist adjuvants. TLR triagonist adjuvants combine different TLR agonists to enhance immune responses to vaccine antigens. We tested both the protective efficacy and reactogenicity of our vaccine candidates in Hartley guinea pigs using intratracheal infection with live\n                    <jats:italic>C. burnetii<\/jats:italic>\n                    . While all of our candidates showed varying degrees of protection during challenge, local reactogenic responses were significantly reduced for one of our vaccine candidates when compared with a formalin-inactivated whole-cell vaccine. Our findings show that subunit vaccines combined with novel TLR triagonist adjuvants can generate protective immunity to\n                    <jats:italic>C. burnetii<\/jats:italic>\n                    infection while reducing reactogenic responses.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2021.653092","type":"journal-article","created":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T01:50:38Z","timestamp":1615945838000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Subunit Vaccines Using TLR Triagonist Combination Adjuvants Provide Protection Against Coxiella burnetii While Minimizing Reactogenic Responses"],"prefix":"10.3389","volume":"12","author":[{"given":"Alycia P.","family":"Fratzke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Jan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiin","family":"Felgner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Algis","family":"Jasinskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saikat","family":"Manna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fnu N.","family":"Nihesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sampa","family":"Maiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler J.","family":"Albin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron P.","family":"Esser-Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Huw","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip L.","family":"Felgner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony E.","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3049","article-title":"Molecular pathogenesis of the obligate intracellular bacterium Coxiella burnetii","volume":"11","author":"Van Schaik","year":"2013","journal-title":"Nat Rev Microbiol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jccase.2019.03.012","article-title":"Myocarditis: A rare manifestation of acute Q fever infection","volume":"20","author":"Jacobson","year":"2019","journal-title":"J Cardiol cases"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-012-1750-3","article-title":"Q fever and pregnancy: Disease, prevention, and strain specificity","volume":"32","author":"Angelakis","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1155\/2012\/131932","article-title":"Q fever: An old but still a poorly understood disease","volume":"2012","author":"Honarmand","year":"2012","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2014.00726","article-title":"Vaccination against Q fever for biodefense and public health indications","volume":"5","author":"Ruiz","year":"2014","journal-title":"Front Microbiol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.371","article-title":"Adaptive Immunity to the Obligate Intracellular Pathogen Coxiella burnetii","volume":"43","author":"Shannon","year":"2009","journal-title":"Immunol Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268800059458","article-title":"Vaccine prophylaxis of abattoir-associated Q fever: Eight years\u2019 experience in Australian abattoirs","volume":"104","author":"Marmion","year":"1990","journal-title":"Epidemiol Infect"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/vaccines6040083","article-title":"Frequency of adverse events following q fever immunisation in young adults","volume":"6","author":"Sellens","year":"2018","journal-title":"Vaccines"},{"key":"B9","article-title":"Immunogenicity and reactogenicity of a Q fever chemovaccine in persons professionally exposed to Q fever in Czechoslovakia","volume":"60","author":"Kazar","year":"1982","journal-title":"Bull World Health Organ"},{"key":"B10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/zph.12658","article-title":"Coxiella burnetii seroprevalence in unvaccinated veterinary workers in Australia: Evidence to support Q fever vaccination","volume":"67","author":"Sellens","year":"2020","journal-title":"Zoonoses Public Health"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S195940","article-title":"Serological evidence of Coxiella burnetii infection in cattle and farm workers: is Q fever an underreported zoonotic disease in Ecuador","volume":"12","author":"Echeverr\u00eda","year":"2019","journal-title":"Infect Drug Resist"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0211781","article-title":"Seroprevalence of Q fever among high-risk occupations in the Ilam province, the west of Iran","volume":"14","author":"Mostafavi","year":"2019","journal-title":"PloS One"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/cti.2016.22","article-title":"Toll-like receptors: The swiss army knife of immunity and vaccine development","volume":"5","author":"Dowling","year":"2016","journal-title":"Clin Transl Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.08.002","article-title":"TLR-based immune adjuvants","volume":"29","author":"Steinhagen","year":"2011","journal-title":"Vaccine"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4110\/in.2015.15.2.51","article-title":"Recent Advances of Vaccine Adjuvants for Infectious Diseases","volume":"15","author":"Lee","year":"2015","journal-title":"Immune Netw"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00046-08","article-title":"Pathogen recognition and inflammatory signaling in innate immune defenses","volume":"22","author":"Mogensen","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibtech.2018.10.004","article-title":"Applications of Immunomodulatory Immune Synergies to Adjuvant Discovery and Vaccine Development","volume":"37","author":"Tom","year":"2019","journal-title":"Trends Biotechnol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1021\/acscentsci.8b00823","article-title":"Linked Toll-Like Receptor Triagonists Stimulate Distinct, Combination-Dependent Innate Immune Responses","volume":"5","author":"Albin","year":"2019","journal-title":"ACS Cent Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.3371","article-title":"In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity","volume":"33","author":"Lynn","year":"2015","journal-title":"Nat Biotechnol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02804-y","article-title":"Combinatorial Delivery of Dual and Triple TLR Agonists via Polymeric Pathogen-like Particles Synergistically Enhances Innate and Adaptive Immune Responses","volume":"7","author":"Madan-Lala","year":"2017","journal-title":"Sci Rep"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1900991","article-title":"Tuning Subunit Vaccines with Novel TLR Triagonist Adjuvants to Generate Protective Immune Responses against Coxiella burnetii","volume":"204","author":"Gilkes","year":"2020","journal-title":"J Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.12.8372","article-title":"Mechanisms of Vaccine-Induced Protective Immunity against Coxiella burnetii Infection in BALB\/c Mice","volume":"179","author":"Zhang","year":"2007","journal-title":"J Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1021\/bc900290d","article-title":"Dendrimers for vaccine and immunostimulatory uses. A review","volume":"21","author":"Heegaard","year":"2010","journal-title":"Bioconjug Chem"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1021\/ja400986u","article-title":"Multifunctional dendronized peptide polymer platform for safe and effective siRNA delivery","volume":"135","author":"Zeng","year":"2013","journal-title":"J Am Chem Soc"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1021\/acscentsci.8b00218","article-title":"Immunomodulation of the NLRP3 Inflammasome through Structure-Based Activator Design and Functional Regulation via Lysosomal Rupture","volume":"4","author":"Manna","year":"2018","journal-title":"ACS Cent Sci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00178-19","article-title":"Coxiella burnetii Intratracheal Aerosol Infection Model in Mice, Guinea Pigs, and Nonhuman Primates","volume":"87","author":"Gregory","year":"2019","journal-title":"Infect Immun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.02826-10","article-title":"Isolation from Animal Tissue and Genetic Transformation of Coxiella burnetii Are Facilitated by an Improved Axenic Growth Medium","volume":"77","author":"Omsland","year":"2011","journal-title":"Appl Environ Microbiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M410340200","article-title":"Stimulation of Toll-like receptor 2 by Coxiella burnetii is required for macrophage production of pro-inflammatory cytokines and resistance to infection","volume":"279","author":"Zamboni","year":"2004","journal-title":"J Biol Chem"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0408782102","article-title":"Profiling the humoral immune response to infection by using proteome microarrays: High-throughput vaccine and diagnostic antigen discovery","volume":"102","author":"Davies","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00297-13","article-title":"Formalin-inactivated Coxiella burnetii phase i vaccine-induced protection depends on b cells to produce protective igm and igg","volume":"81","author":"Zhang","year":"2013","journal-title":"Infect Immun"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.201000064","article-title":"Genome-wide profiling of humoral immune response to Coxiella burnetii infection by protein microarray","volume":"10","author":"Vigil","year":"2010","journal-title":"Proteomics"},{"key":"B32","doi-asserted-by":"publisher","first-page":"M110.006304","DOI":"10.1074\/mcp.m110.006304","article-title":"Profiling the Humoral Immune Response of Acute and Chronic Q Fever by Protein Microarray","volume":"10","author":"Vigil","year":"2011","journal-title":"Mol Cell Proteomics"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00763-06","article-title":"Clinical and pathologic changes in a guinea pig aerosol challenge model of acute Q fever","volume":"74","author":"Russell-Lodrigue","year":"2006","journal-title":"Infect Immun"},{"key":"B34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.idc.2009.10.004","article-title":"Q Fever Pneumonia","volume":"24","author":"Marrie","year":"2010","journal-title":"Infect Dis Clin North Am"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1843.2004.00586.x","article-title":"Clinical features of Q fever pneumonia","volume":"9","author":"Okimoto","year":"2004","journal-title":"Respirology"},{"key":"B36","article-title":"Guinea pig abscess\/hypersensitivity model for study of adverse vaccination reactions induced by use of Q fever vaccines","volume":"50","author":"Wilhelmsen","year":"2000","journal-title":"Comp Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0205882","article-title":"Standardized Guinea pig model for Q fever vaccine reactogenicity","volume":"13","author":"Baeten","year":"2018","journal-title":"PloS One"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01767-06","article-title":"T cells are essential for bacterial clearance, and gamma interferon, tumor necrosis factor alpha, and B cells are crucial for disease development in Coxiella burnetii infection in mice","volume":"75","author":"Andoh","year":"2007","journal-title":"Infect Immun"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1021\/jm301694x","article-title":"Identification of Substituted Pyrimido[5,4\u2212b]indoles as Selective Toll- Like Receptor 4 Ligands","volume":"56","author":"Chan","year":"2013","journal-title":"J Med Chem"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1126\/science.1138963","article-title":"The vaccine adjuvant monophosphoryl lipid A as a TRIF-biased agonist of TLR4","volume":"316","author":"Mata-Haro","year":"2007","journal-title":"Science (80-)"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JVI.01050-17","article-title":"Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice","volume":"91","author":"Goff","year":"2017","journal-title":"J Virol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1126\/science.1085439","article-title":"Toll-Like Receptor Signaling Pathways","volume":"300","author":"Barton","year":"2003","journal-title":"Science (80-)"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1003192","article-title":"TLR4 Signaling via MyD88 and TRIF Differentially Shape the CD4 + T Cell Response to Porphyromonas gingivalis Hemagglutinin B","volume":"186","author":"Gaddis","year":"2011","journal-title":"J Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302569","article-title":"TLR4 Ligands Lipopolysaccharide and Monophosphoryl Lipid A Differentially Regulate Effector and Memory CD8 + T Cell Differentiation","volume":"192","author":"Cui","year":"2014","journal-title":"J Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901593","article-title":"Mice Deficient in MyD88 Develop a Th2-Dominant Response and Severe Pathology in the Upper Genital Tract following Chlamydia muridarum Infection","volume":"184","author":"Chen","year":"2010","journal-title":"J Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00101-10","article-title":"Role of CD4+ and CD8+ T cells in clearance of primary pulmonary infection with Coxiella burnetii","volume":"78","author":"Read","year":"2010","journal-title":"Infect Immun"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20051782","article-title":"TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis","volume":"202","author":"Bafica","year":"2005","journal-title":"J Exp Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.2.1080","article-title":"Central Role of MyD88-Dependent Dendritic Cell Maturation and Proinflammatory Cytokine Production to Control Brucella abortus Infection","volume":"180","author":"Macedo","year":"2008","journal-title":"J Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.02870-14","article-title":"Toll-like receptor 2 (TLR2) and TLR9 play opposing roles in host innate immunity against Salmonella enterica serovar typhimurium infection","volume":"83","author":"Zhan","year":"2015","journal-title":"Infect Immun"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01207","article-title":"A Novel Synthetic Dual Agonistic Liposomal TLR4\/7 Adjuvant Promotes Broad Immune Responses in an Influenza Vaccine With Minimal Reactogenicity","volume":"11","author":"Sato-Kaneko","year":"2020","journal-title":"Front Immunol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41541-018-0057-5","article-title":"The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial","volume":"3","author":"Coler","year":"2018","journal-title":"NPJ Vaccines"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01112","article-title":"The Use of Toll-Like Receptor Agonists in HIV-1 Cure Strategies","volume":"11","author":"Martinsen","year":"2020","journal-title":"Front Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/0003-9861(72)90164-6","article-title":"Guinea Pig Heterophil and Eosinophil Peroxidase","volume":"148","author":"Evans","year":"1972","journal-title":"Arch Biochem Biophys"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/nri3024","article-title":"Neutrophils in the activation and regulation of innate and adaptive immunity","volume":"11","author":"Mantovani","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.immuni.2010.04.010","article-title":"Toll-like receptor 2 signaling in CD4+ T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease","volume":"32","author":"Reynolds","year":"2010","journal-title":"Immunity"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.653092\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T01:50:42Z","timestamp":1615945842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.653092\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,17]]},"references-count":55,"alternative-id":["10.3389\/fimmu.2021.653092"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.653092","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,17]]},"article-number":"653092"}}